Supreme Court of the United States
Skip Navigation LinksHome > Search Results



Docket for 19-1131
RSS Feed Print Notify Me
Search documents in this case:
No. 19-1131
Title:Actavis Laboratories FL, Inc., Petitioner
v.
Nalpropion Pharmaceuticals LLC
Docketed:March 16, 2020
Lower Ct:United States Court of Appeals for the Federal Circuit
   Case Numbers:(2018-1221)
   Decision Date:August 15, 2019
   Rehearing Denied:December 16, 2019
  Discretionary Court Decision Date:

DateProceedings and Orders
Mar 13 2020Petition for a writ of certiorari filed. (Response due April 15, 2020)
PetitionAppendixCertificate of Word CountProof of Service
Apr 15 2020Brief amicus curiae of Association for Accessible Medicines filed.
Main DocumentCertificate of Word CountProof of Service
Apr 15 2020Brief of respondent Nalpropion Pharmaceuticals LLC in opposition filed.
Main DocumentCertificate of Word CountProof of Service
May 04 2020Reply of petitioner Actavis Laboratories FL, Inc. filed. (Distributed)
Main DocumentCertificate of Word CountProof of Service
May 05 2020DISTRIBUTED for Conference of 5/21/2020.
May 26 2020Petition DENIED.

NAMEADDRESSPHONE
Attorneys for Petitioner
William McGinley Jay
    Counsel of Record
Goodwin Procter, LLP
1900 N Street, N.W.
Washington, DC 20036

WJay@goodwinlaw.com
2023464190
Party name: Actavis Laboratories FL, Inc.
Attorneys for Respondent
Dominick A. Conde
    Counsel of Record
Venable LLP
1290 Avenue of the Americas
New York, NY 10104-3800

dconde@venable.com
212-218-2100
Party name: Nalpropion Pharmaceuticals LLC
Other
Matthew S. Hellman
    Counsel of Record
Jenner & Block LLP
1099 New York Ave., NW
Suite 900
Washington, DC 20001

mhellman@jenner.com
202-639-6000
Party name: Association for Accessible Medicines

 

SUPREME COURT OF THE UNITED STATES 1 First Street, NE Washington, DC 20543